Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:55:42.353Z.
Calculation as of: 2026-10-06T14:55:42.353Z.
Quote observation: 2026-10-06T14:52:35.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d554412806125b06490580232e6d80b3120c6a72214b764814008bb1d876b03
PE RATIO
N/A
Market Cap
$9.92M
PE Ratio
N/A
TTM Avg
3.33
3Y Avg
3.33
5Y Avg
3.33
Market Cap
$9.12M
PE Ratio
N/A
TTM Avg
38.25
3Y Avg
38.25
5Y Avg
38.25
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ainos, Inc. (AIMD) | $9.79M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.92M | N/A | 3.33 | 3.33 | 3.33 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $9.98M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.09M | N/A | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.32M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.45M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.12M | N/A | 38.25 | 38.25 | 38.25 |
| Lifeward Ltd. (LFWD)vs › | $10.47M | N/A | N/A | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $8.97M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
